World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
79
Citations
19603
World Ranking
1707
National Ranking
842

Overview

Barbara K. Felber is affiliated with the National Institutes of Health in the United States. Their research focuses primarily on immunology and microbiology, and medicine, with substantial contributions to infectious diseases, virology, oncology, and epidemiology.

The scientist's work spans key topics such as:

  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • HIV Research and Treatment
  • Immune Cell Function and Interaction
  • COVID-19 Clinical Research Studies
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research

Barbara K. Felber has published research in several prominent venues, including:

  • Cancer Research
  • Frontiers in Immunology
  • The Journal of Immunology
  • SSRN Electronic Journal
  • Cell Reports

The scientist frequently collaborates with several co-authors, among them are:

  • George N. Pavlakis (50 joint publications)
  • Margherita Rosati (28)
  • Jenifer Bear (26)
  • Dimitris Stellas (22)
  • Sevasti Karaliota (19)

Representative recent publications by Barbara K. Felber include:

  • Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge, 2020, Cell Reports

Other influential papers associated with the research environment include:

  • Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients, 2021, Cell Reports
  • Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10, 2020, Journal for ImmunoTherapy of Cancer
  • SARS-CoV-2 antibody kinetics eight months from COVID-19 onset: Persistence of spike antibodies but loss of neutralizing antibodies in 24% of convalescent plasma donors, 2021, European Journal of Internal Medicine
  • Heterodimeric IL-15 in Cancer Immunotherapy, 2021, Cancers

Best Publications

  • rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA.

    Barbara K. Felber;Margarita Hadzopoulou-Cladaras;Christos Cladaras;Terry Copeland

  • The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats

    Barbara K. Felber;Harry Paskalis;Carol Kleinman-Ewing;Flossie Wong-Staal

  • Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.

    S Schwartz;B K Felber;D M Benko;E M Fenyö

  • The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region.

    M Hadzopoulou-Cladaras;B K Felber;C Cladaras;A Athanassopoulos

  • Efficient production and enhanced tumor delivery of engineered extracellular vesicles.

    Dionysios C. Watson;Defne Bayik;Avinash Srivatsan;Cristina Bergamaschi

  • Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression.

    S Schwartz;M Campbell;G Nasioulas;J Harrison

  • Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation.

    R Schneider;M Campbell;G Nasioulas;B K Felber

  • Env and Vpu proteins of human immunodeficiency virus type 1 are produced from multiple bicistronic mRNAs.

    S Schwartz;B K Felber;E M Fenyö;G N Pavlakis

  • Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein.

    S Schwartz;B K Felber;G N Pavlakis

  • Expression and characterization of the trans-activator of HTLV-III/LAV virus

    Connie M. Wright;Barbara K. Felber;Harry Paskalis;George N. Pavlakis

  • A quantitative bioassay for HIV-1 based on trans-activation.

    Barbara K. Felber;George N. Pavlakis

  • Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys.

    Sampa Santra;Hua-Xin Liao;Ruijin Zhang;Mark Muldoon

  • The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.

    D M D'Agostino;B K Felber;J E Harrison;G N Pavlakis

  • Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes.

    A S Zolotukhin;A Valentin;G N Pavlakis;B K Felber

  • Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I.

    V Ciminale;G N Pavlakis;D Derse;C P Cunningham

  • The simian retrovirus-1 constitutive transport element, unlike the HIV-1 RRE, uses factors required for cellular mRNA export

    Claudio A. Saavedra;Barbara Anna Felber;Elisa Izaurralde

  • Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques.

    Amara Luckay;Maninder K. Sidhu;Rune Kjeken;Shakuntala Megati

  • Circulating IL-15 exists as heterodimeric complex with soluble IL-15Rα in human and mouse serum.

    Cristina Bergamaschi;Jenifer Bear;Margherita Rosati;Rachel Kelly Beach

  • Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

    Michele A. Kutzler;Tara M. Robinson;Michael A. Chattergoon;Daniel K. Choo

  • Nucleoporins Nup98 and Nup214 Participate in Nuclear Export of Human Immunodeficiency Virus Type 1 Rev

    Andrei S. Zolotukhin;Barbara K. Felber

  • Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.

    Zdenek Hel;Janos Nacsa;Elzbieta Tryniszewska;Wen-Po Tsai

Frequent Co-Authors

George N. Pavlakis
George N. Pavlakis Emory University
David C. Montefiori
David C. Montefiori Duke University
Niranjan Y. Sardesai
Niranjan Y. Sardesai University of Pennsylvania
David Venzon
David Venzon National Institutes of Health
Genoveffa Franchini
Genoveffa Franchini National Institutes of Health
Marjorie Robert-Guroff
Marjorie Robert-Guroff National Institutes of Health
David B. Weiner
David B. Weiner The Wistar Institute
James I. Mullins
James I. Mullins University of Washington
Celia C. LaBranche
Celia C. LaBranche Duke University
Georgia D. Tomaras
Georgia D. Tomaras Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. Nursing programs often serve as a solid foundation, with many options available online. Students looking for accessible options might consider the easiest accelerated nursing programs to get into, which provide efficient pathways into the nursing profession while maintaining rigorous standards.

Licensed Practical Nurse (LPN) programs are another entry point into healthcare, offering hands-on clinical experience. If accessibility is a concern, reviewing the which lpn programs are easiest to get into can help identify programs that offer flexible admission criteria and support.

For advanced practice, nurse practitioner degrees open doors to specialized roles in patient care. Prospective students should consider the easiest nurse practitioner program options to find accelerated and supportive environments that balance academic rigor with accessibility.

Specifically, those focused on mental health can explore Psychiatric-Mental Health Nurse Practitioner (PMHNP) programs, which combine clinical expertise with immunological knowledge in some areas. The top pmhnp programs are known for strong clinical placement rates, ensuring practical experience that is critical for career success.

Best Scientists Citing Barbara K. Felber

Trending Scientists